Lipo-C Peptide Injection Blend: Research Guide | QSC Peptides
QSC RESEARCH PRODUCT — INJECTION BLEND
Lipo-C: Lipotropic Peptide Injection Blend Research Guide
Lipo-C is a lipotropic injection blend combining compounds with complementary mechanisms for fat metabolism, energy utilisation, and hepatic lipid processing research. This page covers the components, mechanisms, research applications, and QSC quality standard for Lipo-C injection blend research kits.
What Is Lipo-C?
Lipo-C is a multi-compound lipotropic injection blend. The standard formulation combines several fat metabolism and energy-related compounds into a single injectable research preparation. Individual components each address distinct aspects of lipid metabolism and hepatic function.
Typical Lipo-C component
Class
Mechanism
Research role
MIC (Methionine, Inositol, Choline)
Lipotropic agents
Hepatic lipid export, phospholipid synthesis, fatty acid transport
Liver lipid processing, hepatic steatosis model
L-Carnitine
Amino acid derivative
Fatty acid transport into mitochondria for β-oxidation
Mitochondrial fat oxidation research
Thiamine (B1)
B-vitamin
Pyruvate dehydrogenase cofactor → carbohydrate → energy
Energy metabolism, glucose utilisation
Riboflavin (B2)
B-vitamin
FAD cofactor for ETC Complex I/II — fat oxidation
Mitochondrial respiration
Pyridoxine (B6)
B-vitamin
Amino acid metabolism, gluconeogenesis cofactor
Metabolic substrate utilisation
Cyanocobalamin (B12)
B-vitamin
One-carbon metabolism, methionine cycle
Hepatic methylation, lipid export
L-Glutathione (reduced)
Tripeptide antioxidant
ROS scavenging, xenobiotic conjugation
Hepatic antioxidant capacity research
Why combine these compounds?
The MIC triad (methionine, inositol, choline) directly supports hepatic phosphatidylcholine synthesis — essential for VLDL assembly and hepatic fat export. L-carnitine provides the mitochondrial fat transport mechanism. B-vitamins support the enzymatic infrastructure for both pathways. Glutathione protects hepatocytes from oxidative stress during high-fat catabolism. Together they address multiple nodes of lipid metabolism simultaneously.
Mechanism: Hepatic Lipid Export Pathway
Step
Compound involved
Mechanism
1. Choline → Phosphatidylcholine
Choline (MIC)
CDP-choline pathway → PC synthesis → VLDL particle surface component
2. VLDL assembly
Choline + B12 + methionine
PC-coated VLDL particles package hepatic triglycerides for export
Cofactors for fat-to-acetyl-CoA conversion → Krebs cycle
6. Oxidative protection
Glutathione
GSH/GSSG redox — prevents lipid peroxidation during high fat catabolism
Research Applications
Non-alcoholic fatty liver disease (NAFLD) model
High-fat diet (HFD) C57BL/6 mouse → 12-week NAFLD induction → Lipo-C treatment × 4-8 weeks. Primary: liver TG (Folch extraction), liver histology (Oil Red O, NAS score), plasma ALT/AST, VLDL-TG output assay. Compare individual components vs full blend to identify mechanistic drivers of hepatic lipid reduction.
Body composition research
DIO (diet-induced obese) mouse model. Lipo-C + pair-fed control + ad libitum control. EchoMRI (fat mass, lean mass), RER (metabolic cage), glucose tolerance test. Establishes carnitine-mediated fat oxidation contribution to body composition independent of caloric restriction.
Hepatic methylation and lipid export
Primary hepatocytes. Methionine/choline deficiency (MCD) medium → lipid accumulation. Add individual MIC components + B12. Quantify: cellular TG (triglyceride kit), VLDL secretion (ApoB ELISA in media), intracellular lipid (Oil Red O). Dissects individual MIC contributions.
❓
Frequently Asked Questions
What is Lipo-C?
Lipo-C is a lipotropic injection blend combining MIC (methionine, inositol, choline), L-carnitine, B-vitamins (B1, B2, B6, B12), and glutathione. It is used in research investigating hepatic lipid export, mitochondrial fat oxidation, and body composition biology.
What does “lipotropic” mean?
Lipotropic refers to substances that promote fat metabolism or prevent abnormal fat accumulation in the liver. Choline and inositol are the primary lipotropic agents in Lipo-C — they support phosphatidylcholine synthesis for VLDL assembly and hepatic triglyceride export.
Why is L-carnitine in the Lipo-C blend?
L-carnitine is the essential cofactor for mitochondrial fatty acid import. CPT1 (carnitine palmitoyltransferase 1) converts long-chain fatty acids to acylcarnitines for transport across the inner mitochondrial membrane into the matrix for β-oxidation. Without adequate carnitine, fatty acid entry into the mitochondria is rate-limited.
How does Lipo-C differ from individual compound research?
Individual compounds address single mechanisms. The blend addresses multiple simultaneously — hepatic export (choline/inositol), mitochondrial import (carnitine), enzymatic cofactors (B-vitamins), and oxidative protection (glutathione). For research dissecting which component drives which effect, factorial designs with individual components vs the blend are the appropriate approach.
